Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0000950170-25-044345

Options or other derivatives

  • SVP, GENERAL COUNSEL acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sandercock Colin SVP, GENERAL COUNSEL 2025-03-21 Grant or award · Stock Option (right to buy) +200,000 200,000 D
Loading xslF345X05/ownership.xml…